Sage Journals: Discover world-class research

Open access

Research article

First published 2015-1

Efficacy and safety of delayed-release dimethyl fumarate in patients newly diagnosed with relapsing–remitting multiple sclerosis (RRMS)

Ralf Gold, Gavin Giovannoni, J Theodore Phillips [...]

Multiple Sclerosis Journal

Open access

Research article

First published 2016-2

Delayed-release dimethyl fumarate and disability assessed by the Multiple Sclerosis Functional Composite: Integrated analysis of DEFINE and CONFIRM

Gavin Giovannoni, Ralf Gold, Ludwig Kappos [...]

Multiple Sclerosis Journal – Experimental,Translational and Clinical

Open access

Research article

First published 2017-2

Long-term effects of delayed-release dimethyl fumarate in multiple sclerosis: Interim analysis of ENDORSE,a randomized extension study

Ralf Gold, Douglas L Arnold, Amit Bar-Or [...]

Multiple Sclerosis Journal

Open access

Research article

First published 2020

Safety and efficacy of delayed-release dimethyl fumarate in patients with relapsing-remitting multiple sclerosis: 9 years’ follow-up of DEFINE,CONFIRM,and ENDORSE

Ralf Gold, Douglas L. Arnold, Amit Bar-Or [...]

Therapeutic Advances in Neurological Disorders

Open access

Research article

First published 2019-10

Gut microbiota composition during a 12-week intervention with delayed-release dimethyl fumarate in multiple sclerosis – a pilot trial

C Storm-Larsen, K-M Myhr, E Farbu [...]

Multiple Sclerosis Journal – Experimental,Translational and Clinical

Retricted access

Research article

First published 2017-12

Evidence of activation of the Nrf2 pathway in multiple sclerosis patients treated with delayed-release dimethyl fumarate in the Phase 3 DEFINE and CONFIRM studies

Sreeja Gopal, Alvydas Mikulskis, Ralf Gold [...]

Multiple Sclerosis Journal

Open access

Research article

First published 2019-10

Effectiveness of delayed-release dimethyl fumarate on patient-reported outcomes and clinical measures in patients with relapsing–remitting multiple sclerosis in a real-world clinical setting: PROTEC

T Berger, B Brochet, L Brambilla [...]

Multiple Sclerosis Journal – Experimental,Translational and Clinical

Open access

Research article

First published 2018

Incidence and mitigation of gastrointestinal events in patients with relapsing–remitting multiple sclerosis receiving delayed-release dimethyl fumarate: a German phase IV study (TOLERATE)

Ralf Gold, Eugen Schlegel, Birte Elias-Hamp [...]

Therapeutic Advances in Neurological Disorders

Open access

Research article

First published 2021-5

Dimethyl fumarate treatment shifts the immune environment toward an anti-inflammatory cell profile while maintaining protective humoral immunity

Erin E Longbrake, Yang Mao-Draayer, Mark Cascione [...]

Multiple Sclerosis Journal

Open access

Correction

First published 2020

Corrigendum to “Safety and Efficacy of Delayed-Release Dimethyl Fumarate in Patients with Relapsing-Remitting Multiple Sclerosis: 9 Years’ Follow-up of DEFINE,CONFIRM,and ENDORSE”

Therapeutic Advances in Neurological Disorders

Search results